Arca
Skip to content
Tools
Tools

Chronic pain

Drug research and approvals for chronic pain: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 905 studies of chronic pain are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, FDA has 2 approved and 0 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 905
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 2
  • EU medicines: 1

Recruiting now

Newest posted first, of 905 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 9

Phase 3 12 of 20

Phase 2 12 of 17

Phase 1 or earlier 12 of 20

How its trials ended

2,485 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 398 whose ending is known, 44% met their primary endpoint, 6% missed it and 50% stopped early.

  • Completed, result not reported1,13546%
  • Ongoing63826%
  • Status unknown31413%
  • Met its primary endpoint1757%
  • Stopped: other or unclear1175%
  • Stopped: enrollment or feasibility492%
  • Missed its primary endpoint231%
  • Stopped: sponsor or business decision141%
  • Stopped: funding12<1%
  • Stopped: lack of efficacy6<1%
  • Stopped: safety2<1%

FDA orphan designations

Approved first, then open designations, newest first
Mar 19, 1999Lidoderm PatchFor relief of allodynia (painful hypersensitivity), and chronic pain in postherpetic neuralgia.Teikoku Pharma USA, Inc.Approved
Jul 19, 1991InfumorphFor intrathecal or epidural infusion in the treatment of tractable chronic pain. It was developed for use in continuous microinfusion…Elkins-Sinn, Inc.Approved

Medicines authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Feb 21, 2005PrialtZiconotideEsteve Pharmaceuticals GmbHEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.